CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Brief Summary:The FREEDOM study aims to develop a scalable intervention to improve type 2 diabetes mellitus control in low-income Black adul...
Birmingham, Alabama, United States
Objectives The objective of this clinical trial is to assess whether ladarixin treatment has an effect to preserve β-cell function and delay the prog...
Phase 2
Birmingham, Alabama, United States and 56 other locations
This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing ...
Phase 4
Birmingham, Alabama, United States and 89 other locations
The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...
Phase 3
Birmingham, Alabama, United States and 654 other locations
double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes...
Phase 2
Vestavia Hills, Alabama, United States and 103 other locations
weight in adult participants with obesity or overweight and type 2 diabetes. The study will last about 77 weeks and may include up to 22 vis...
Phase 3
Pelham, Alabama, United States and 138 other locations
This study will evaluate the safety and efficacy of ertugliflozin (MK-8835) in pediatric participants with T2DM on metformin with/without insulin. Th...
Phase 3
Birmingham, Alabama, United States and 103 other locations
The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants w...
Phase 3
Cullman, Alabama, United States of America and 101 other locations
The purpose of this study is to investigate the efficacy and safety of retatrutide compared with semaglutide in participants with Type 2 Diabetes...
Phase 3
Birmingham, Alabama, United States and 79 other locations
This study will look at how well CagriSema helps people with type 2 diabetes lower their blood sugar and body weight. CagriSema is a new inv...
Phase 3
Birmingham, Alabama, United States and 185 other locations
Clinical trials
Research sites
Resources
Legal